Publications by authors named "Steven D Nathan"

Claim this Profile
P
Plasma Cell-free DNA Associated With Risk of Mortality and Chronic Lung Allograft Dysfunction Among Lung Transplant Recipients With .
Yasir Hamad, Joby Mathew, Temesgen Andargie, Steven D Nathan, Hyesik Kong

Transplant Direct· January 2026

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reply to Zeng: Redefining Accelerated Pulmonary Hypertension in Idiopathic Pulmonary Fibrosis: Uncovering Treatment Effects and Novel Triggers.
Steven D Nathan, Ho Cheol Kim, Christopher King, Abhimanyu Chandel

Am J Respir Crit Care Med· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of donor specific antibodies on longitudinal lung function and baseline lung allograft dysfunction.
Muhtadi Alnababteh, Junfeng Sun, Rohan Meda, Lucia Ponor, Pali Shah, Steven D Nathan, Jonathan B Orens

J Heart Lung Transplant· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development and validation of a predictive 6-min walk score in patients with idiopathic pulmonary fibrosis.
Steven D Nathan, Jie Gao, Ho Cheol Kim, Abhimanyu Chandel, Henry Chen

Eur Respir J· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Molecular criteria for pulmonary antibody-mediated rejection are associated with an increased risk of allograft failure.
Michael B Keller, David Newman, Muhtadi Alnababteh, Ann Bon, Lucia Ponor, Steven D Nathan, Jonathan B Orens

J Heart Lung Transplant· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pulmonary Hypertension Associated with Interstitial Lung Disease: Screening and Epidemiology.
Cedric Rutland, Chase S Hall, Nicholas A Kolaitis, Tejaswini Kulkarni, Lisa H Lancaster, Steven D Nathan

ATS Sch· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Donor-derived cell-free DNA is associated with the degree of immunosuppression in lung transplantation.
Ananth V Charya, Moon K Jang, Hyesik Kong, Woojin Park, Xin Tian, Jonathan B Orens, Steven D Nathan

Am J Transplant· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Incidence Rate and Prevalence of Idiopathic Pulmonary Fibrosis in the United States 2017-2022.
Yanni Fan, Haikun Bao, Pratik Pimple, Amy L Olson, Steven D Nathan

Ann Am Thorac Soc· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The effect of antifibrotics on the progression of pulmonary hypertension in patients with interstitial lung disease listed for lung transplantation.
Christopher Thomas, Abhimanyu Chandel, Mira Zineddin, Charles Tang, Ho Cheol Kim, Steven D Nathan

BMC Pulm Med· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Early phase clinical trials in pulmonary hypertension: how small is big enough?
Steven D Nathan

Thorax· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sustained Molecular Allograft Injury After Episodes of Acute Rejection and Organizing Pneumonia Increases the Risk of Lung Allograft Failure.
Michael B Keller, Allison Y Lin, Moon Kyoo Jang, Hyesik Kong, Ananth Charya, Jonathan B Orens, Steven D Nathan

Transplant Direct· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The potential clinical implications of slow vital capacity in patients with idiopathic pulmonary fibrosis.
Ho Cheol Kim, Sydney Guthrie, Christopher S King, Shazia Khan, Christopher A Thomas, Steven D Nathan

Respir Res· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hemodynamic Patterns in Interstitial Lung Disease: A Snapshot of Clinical Practice and a Roadmap for Future Trials.
Ho Cheol Kim, Christopher S King, Christopher A Thomas, Jared Wilkinson, Junad Chowdhury, Steven D Nathan

Pulm Circ· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of College Summer Student Experience at an Advanced Lung Disease and Transplant Program.
Steven D Nathan, Shambhu Aryal, Edwinia Battle, A Whitney Brown, Megan Harbour

ATS Sch· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Early Post-Transplant Recipient Tissue Injury Predicts Allograft Function, Rejection, and Survival in Lung Transplant Recipients, Evidence from Cell-free DNA.
Muhtadi Alnababteh, Michael B Keller, Hyesik Kong, Kellie Phipps, Jackson Namian, Jonathan B Orens, Steven D Nathan

Eur Respir J· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Significance of Pulmonary Vascular Dysfunction in Chronic Obstructive Pulmonary Disease.
Steven D Nathan, Lucilla Piccari, Steven H Abman, Aparna Balasubramanian, Reda E Girgis

Pulm Circ· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Serial Pulmonary Hemodynamics in Patients with Idiopathic Pulmonary Fibrosis Listed for Lung Transplant.
Steven D Nathan, Ho Cheol Kim, Christopher S King, Shambhu Aryal, Christopher Thomas

Am J Respir Crit Care Med· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Physician perspectives on pulmonary hypertension in ILD: results of a cases-based survey.
Ho Cheol Kim, Christopher S King, Christopher Thomas, Vikramjit Khangoora, Osman Malik, Steven D Nathan

BMC Pulm Med· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Future treatment paradigms in pulmonary arterial hypertension: a personal view from physicians, health authorities, and patients.
Franck F Rahaghi, Marc Humbert, Marius M Hoeper, R James White, Robert P Frantz, Steven D Nathan

Lancet Respir Med· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
SARS-CoV-2 Immune Complex-Mediated Neutrophil Activation.
Kiana C Allen, Seth Warner, Heather L Teague, Marcos J Ramos-Benitez, Rui Miao, Steven D Nathan

Open Forum Infect Dis· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Surfactant Protein D and Club Cell Secretory Protein as Biomarkers of Disease Severity and Fostamatinib Efficacy in Severe COVID-19.
Marcos J Ramos-Benitez, Rui Miao, Andrea P Rivera-Torres, Mercedes Lacourt-Ventura, Sonya J Malavez-Cajigas, Steven D Nathan

Crit Care Explor· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Review of the Diagnosis and Management of Pulmonary Hypertension Associated with Interstitial Lung Disease (ILD-PH).
Zein Kattih, Ho Cheol Kim, Shambhu Aryal, Steven D Nathan

J Clin Med· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Shining a spotlight on pulmonary hypertension associated with interstitial lung disease care: The latest advances in diagnosis and treatment.
Steven D Nathan, Michael R Stinchon, Sara Atcheson, Laura Simone, Marykate Nelson

J Manag Care Spec Pharm· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Performance of the FORD Versus Other Available Models for the Noninvasive Prediction of Pulmonary Hypertension in Patients with Interstitial Lung Disease.
Ho Cheol Kim, Abhimanyu Chandel, Christopher S King, Min Jee Kim, Malek Shawabkeh, Steven D Nathan

Lung· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discrepancy between pulmonary arterial wedge pressure and left ventricular end diastolic pressure in patients with interstitial lung disease.
Ho Cheol Kim, Onix Cantres Fonseca, Behnam N Tehrani, Christopher S King, Christopher Thomas, Steven D Nathan

JHLT Open· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis